3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Atopic Eczema: new trials by email Literature Review of Atopic Eczema trials Research Report on Atopic Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema LAS 41002, Active - Atopic Eczema | Phase 2 | Completed | Almirall, S.A. | 20 | 2010-02-01 | 2010-07-12 |
| A Phase 2a Study to Investigate the Effects of Repeated Administration of AeroDerm in Subjects With Atopic Eczema Aeroderm (also known as pitrakinra, AER 001, BAY 16-9996), placebo - Atopic Eczema | Phase 2 | Completed | Aerovance, Inc. | 25 | 2006-02-01 | 2008-05-13 |
| Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage Omalizumab (Xolair®) - Atopic Dermatitis, Atopic Eczema | Phase 2 | Completed | Technical University of Munich | 2012-01-10 |
Dermatitis, Atopic (3) · Hypersensitivity (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Dermatitis (3) · Genetic Diseases, Inborn (3) · Hypersensitivity, Immediate (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Eczematous (3) · Skin Diseases, Genetic (3) · Skin and Connective Tissue Diseases (3) · Hypersensitivity (2)
5-methoxy-methylindoleacetic acid (1) · Exercise (1) · Omalizumab (1) · pitrakinra (1)
Aerovance, Inc. (1) · Almirall, S.A. (1) · Technical University of Munich (1)
Germany (2) · United Kingdom (1)
Christoph Willers, MD, MBA (1) · Darren Wilbraham, MBBS (1) · Richard Groves, FRCP (1) · Stephan Weidinger, Prof.Dr.med. (1)
2009 (1)